Trial intelligence / Profile preview

CRx-401 in Type 2 Diabetes on Metformin

NCT00506298Phase 2Completed

Sponsor
CombinatoRx
Start
Jul 2007
Primary completion
Apr 2009
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of bezafibrate + diflunisal in type 2 diabetes mellitus (T2DM), sponsored by CombinatoRx. Started Jul 2007; status: completed.

02

Drugs

bezafibrate + diflunisal
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00506298.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00506298.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call